Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 3, 2011, Pages 702-710

  Mayer, Eckhard ^a   Jenkins, David ^b   Lindner, Jaroslav ^c   D'Armini, Andrea ^d   Kloek, Jaap ^e   Meyns, Bart ^f   Ilkjaer, Lars Bo ^g   Klepetko, Walter ^h   Delcroix, Marion ^f   Lang, Irene ^h   Pepke Zaba, Joanna ^b   Simonneau, Gerald ⁱ   Dartevelle, Philippe ^j  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ HÔPITAL ANTOINE BÉCLÈRE   (France)

^j CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

more..

Author keywords

chronic thromboembolic pulmonary hypertension; CL; computed tomography; confidence limit; CT; CTEPH; mean pulmonary artery pressure; mPAP; New York Heart Association; NYHA; odds ratio; OR; PAH; PEA; pulmonary arterial hypertension; pulmonary endarterectomy; pulmonary vascular resistance; PVR

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CATHETER INFECTION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL TRIAL; DISEASE COURSE; ENDARTERECTOMY; EUROPE; EXERCISE; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; LUNG EDEMA; LUNG EMBOLISM; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; NEUROLOGIC DISEASE; PERICARDIAL EFFUSION; PERIOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SURGICAL MORTALITY; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 79951727777     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.11.024     Document Type: Article

References (25)

1. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990;81:1735-43. (Pubitemid 20183821)
2. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113:2011-20.
3. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-64.
4. Bonderman D, Wilkens H, Wakounig S, Schafers HJ, Jansa P, Lindner J, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33:325-31.
5. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81:151-8.
6. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76:1457-64. (Pubitemid 37378293)
7. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:637-48. (Pubitemid 38456010)
8. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:595-600. (Pubitemid 38456003)
9. Reichenberger F, Voswinckel R, Enke B, Rutsch M, El Fechtali E, Schmehl T, et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2007;30:922-7. (Pubitemid 351194796)
10. Jais X, D'Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52:2127-34.
11. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 2004;25:2243-78.
12. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33:332-8.
13. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122-7. (Pubitemid 351717571)
14. Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg. 2008;14:274-82.
15. Reich DL, Uysal S, Sliwinski M, Ergin MA, Kahn RA, Konstadt SN, et al. Neuropsychologic outcome after deep hypothermic circulatory arrest in adults. J Thorac Cardiovasc Surg. 1999;117:156-63. (Pubitemid 29022261)
16. Hagl C, Ergin MA, Galla JD, Lansman SL, McCullough JN, Spielvogel D, et al. Neurologic outcome after ascending aorta-aortic arch operations: effect of brain protection technique in high-risk patients. J Thorac Cardiovasc Surg. 2001;121:1107-21.
17. Hartz RS, Byrne JG, Levitsky S, Park J, Rich S. Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg. 1996;62:1255-60. (Pubitemid 26383516)
18. Thomson B, Tsui SS, Dunning J, Goodwin A, Vuylsteke A, Latimer R, et al. Pulmonary endarterectomy is possible and effective without the use of complete circulatory arrest-the UK experience in over 150 patients. Eur J Cardiothorac Surg. 2008;33:157-63.
19. Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007;115:2153-8. (Pubitemid 46659067)
20. Matsuda H, Ogino H, Minatoya K, Sasaki H, Nakanishi N, Kyotani S, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2006;82:1338-43. (Pubitemid 44429915)
21. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161(2 Pt 1):487-92. (Pubitemid 30129457)
22. Suntharalingam J, Goldsmith K, Toshner M, Doughty N, Sheares KK, Hughes R, et al. Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension. Respir Med. 2007;101:2254-62. (Pubitemid 47484789)
23. Mayer E, Dahm M, Hake U, Schmid FX, Pitton M, Kupferwasser I, et al. Midterm results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 1996;61:1788-92. (Pubitemid 26179731)
24. Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009;120:1248-54.
25. Reesink HJ, Surie S, Kloek JJ, Tan HL, Tepaske R, Fedullo PF, et al. Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2009;139:85-91.